MDS1‐EVI1 complex (MECOM) rearrangements, which involve the GATA2 gene, have been identified as an adverse risk factor in AML based on the 2022 European LeukemiaNet risk stratification.12, 39, 40, 41. Here, RUNX1 is linked to acute myeloid leukemia.